Had Covid? You may need only one dose of vaccine, study suggests

By Cassandra Willyard Shannon Romano, a molecular biologist, came down with Covid late last March, about a week after she and her colleagues shut down their lab at Mount Sinai Hospital. A debilitating headache came first, followed by a fever that kept rising, and then excruciating body aches. “I couldn’t sleep. I couldn’t move,” she said. “Every one of my joints just hurt inside.” It was not an experience she wanted to repeat — ever. So when she became eligible for the Covid-19 vaccine recently, she got the shot. Two days after her injection, she developed symptoms that felt very familiar. “The way my head hurt and the way my body ached was the same headache and body ache I had when I had Covid,” she said. .... read more

Completion of 200 Episodes Special Edition

We have come a long way with your love and support. Join us today on MEDtalks with Dr K K Aggarwal COVID edition, at 6:00 PM as we celebrate the completion of 200 episodes in a special edition with Mr Govind Gupta.Just click on www.facebook.com/drkkaggarwal or https://perfecthealthmela.com/vevent2/hall1a.php

Prevention of Heart Disease during Current Times

It is as important to prevent heart disease during the current times, amid the ongoing pandemic, as it was earlier. Join us today on MEDtalks with Dr K K Aggarwal COVID edition, at 7:00 PM to know from the experts how you can take care of your heart and prevent heart disease.Just click on www.facebook.com/drkkaggarwal or https://perfecthealthmela.com/vevent2/hall1a.php

CMAAO Coronavirus Facts And Myth Buster: J&J vaccine

With input from Dr Monica Vasudev 1341: J&J COVID-19 Vaccine Effective Against Severe Disease1.Johnson & Johnsons single dose vaccine candidate against COVID-19 has been found to be 66% effective against moderate to severe COVID-19, reported a multinational phase III trial. The vaccine efficacy was 72% in the U.S. cohort. 2.According to interim data, there were 468 symptomatic cases of COVID-19 among 43,783 adult participants in the U.S., Latin America and South Africa, included in the ENSEMBLE trial. The vaccine met the co-primary endpoints - protection against symptomatic COVID-19 at day 14 and day 28 after vaccination. .... read more

World COVID Meter 2nd February 2021: Acute manageable immunogenic thrombogenic inflammatory contagious viral disease pandemic

Cases: 1M April 2, 2M April 15, 3M April 27, 4M May 8, 5M May 20, 6M May 30, 7M June 7, 8M June 15, 9M June 22, 10M June 29th, 11M July 4, 12M July 8, 13M July 13, 14M July 17, 15M July 23, 16M July 25, 17M July 29, 18M August 1, 19M August 6, 20M August 10, 21M August 16, 22M August 19, 23M August 21, 24M August 27, 25M August 30, 26M September 3, 27M September 7, 28M September 10, 29M September 14, 30M September 18, 31M September 21, 32M September 23, 33M September 28, 34M October 1, 35M October 4, 36M October 8, 37M October 11, 38M October 14, 39M October 17, 40M October 19, 41M October 22, 42M October 24, 43M October 26, 44M October 28, 45M October 30, 46M November 2, 47M November 4, 48M November 6, 49M November 7, 50M November 8, 51M November 10, 52M November 12, 53M November 14, 54M November 15, 55M November 17, 56M November 19, 57M November 20, 58M November 22, 59M November 24, 60M November 25, 61M November 27, 62M November 29, 63M December 1, 64M December 2, 65M December 4, 66M December 6, 67M December 7, 68M December 9, 69M December 10, 70M December 12, 71M December 13, 72M December 14, 73M December 15, 74M December 17, 75M December 19, 76M December 20, 77M December 22, 78M December 23, 79M December 26, 80M December 27, 81M December 29, 82M December 30, 83M December 31, 84M January 2, 85M January 4, 86M January 6, 87M January 7, 88M January 8, 89M January 9, 90M January 10, 91M January 12, 92M January 14, 93M January 15, 94M January 17, 95M January 18, 96M January 20, 97M January 21, 98M January 23, 99M January 25, 100M January 26, 101M January 29, 102M January 30 Ground Zero: Wuhan - in live animal market or cafeteria for animal pathogens: 10th January; Total cases are based on RT PCR, 67% sensitivity Coronavirus Cases: 103,918,498,Deaths: 2,246,954,Recovered: 75,708,857 .... read more

Be Positive, Be Different and Be Persistent

You should be not only positive, different but also persistent. Of the 10 incarnations of Lord Vishnu, the first was a fish, which indicates to be different in life. The second incarnation is tortoise, which indicates that you should be different but learn to withdraw when the need arises. The third is a boar, which indicates persistence. .... read more

Healthcare News Monitor

Sputnik V has 91.6% efficacy in Russian trials: Lancet study

health.economictimes.indiatimes.com

HYDERABAD: Even as Russian Covid-19 vaccine Sputnik V is eyeing an emergency use authorisation (EUA) rollout in India in March, medical journal Lancet has said the vaccine has shown an efficacy of 91.6% against symptomatic Covid-19 in a two-dose regimen. The peer-reviewed journal published interim analysis data of Phase III trials of the vaccine involving over 20,000 adults in Russia on Tuesday. It also tweeted that a sub-analysis of over 2,000 participants aged over 60 years suggested the vaccine was similarly effective and well tolerated in the elderly as well.

Oxford Kept COVID-19 Vaccine Trial Volunteers in Dark About Dosing Error, Letter Shows

expresspharma.in

About 1,500 of the initial volunteers in a late-stage clinical trial of the Oxford/AstraZeneca COVID-19 vaccine were given the wrong dose, but weren’t informed that a mistake had been made after the blunder was discovered, documents obtained by Reuters show. Instead, the dosing mishap was presented to the trial participants in a letter dated June 8 as an opportunity for University of Oxford researchers to learn how well the vaccine works at different doses. The letter was signed by the trial’s chief investigator, Oxford professor Andrew J. Pollard, and sent to the trial subjects.

Covid antibodies remain six months after infection: Study

livemint

The vast majority of people who contract Covid-19 still have antibodies at least six months after infection, a new study involving more than 20,000 people showed. Some 88% of participants who tested positive for a previous infection retained antibodies for six months, according to the report by UK Biobank, a major biomedical database. The number was 99% at three months.

Why you must include fresh turmeric root in your diet: An Ayurvedic expert explains

The Indian Express

Of the many herbs found in the kitchen, raw and fresh ones are considered Ayurvedically powerful for one’s body. Consuming them regularly can benefit the body in many ways. If you have been thinking about making certain lifestyle changes, then start with having fresh turmeric root. Here’s what Ayurvedic practitioner Geeta Vara had to say about the same in an Instagram post. “This is the fresh rhizome of turmeric. This wonder spice is the star of the hip and healthy golden milk or turmeric latte drink. Turmeric has been used for its medicinal properties in Ayurveda for over 5,000 years, so it’s no wonder the natural healing properties have stood the test of time,” she said.